Climate Change Data

Servier SAS

Climate Impact & Sustainability Data (2020, 2020-2021, 2021-2022, 2022-2023)

Reporting Period: 2020

Environmental Metrics

Total Carbon Emissions:1,013,679 tons of CO2 (compared to 2015/2016)
Scope 1 Emissions:6% of total emissions
Scope 2 Emissions:5% of total emissions
Scope 3 Emissions:89% of total emissions
Renewable Energy Share:Not disclosed
Total Energy Consumption:199,555,548 KWh (2019/2020)
Water Consumption:621,737 m3 (2019/2020)
Waste Generated:Not disclosed
Carbon Intensity:1.2 kg of CO2/box of medicine

ESG Focus Areas

  • Product safety and quality
  • Anti-counterfeiting
  • Ecodesign
  • Global approach to health care
  • Business ethics
  • Responsible purchasing
  • Ethics and transparency of clinical trials
  • Responsible marketing and promotion
  • Stakeholder engagement
  • Health and safety at work
  • Employee well-being
  • Diversity, Inclusion and equal opportunities
  • Managerial practices
  • Access to health care
  • Local development and community engagement
  • Climate change and responsible use of resources
  • Effluent and waste management

Environmental Achievements

  • 60.93% of waste from the Group’s industrial R&D sites was recycled in 2019/2020
  • Energy usage of production and R&D sites in France remained constant (down slightly by 1.25%) in the 2019/2020 financial year, even though production increased
  • Amount of water used at production and R&D sites in France fell by 4.58% in 2019/2020
  • Arklow site in Ireland sent zero waste to landfill since 2013
  • Servier Research and Development Institute in Paris-Saclay aiming for BiodiverCity® accreditation

Social Achievements

  • Employee engagement rate reached 55% in 2020 (15 points higher than 2019)
  • 86% of employees surveyed in 2020 said they were proud to work for the Group
  • 79% of employees in France took training in 2019/2020, completing a total of 79,286 hours
  • 3.2 Lost Time Injury Rate (LTIR)
  • 649 people recruited in 2019/2020 (including 155 people on work-study contracts and 211 interns)
  • Solidarity initiatives set up by employees in 37 countries to accompany care workers and associations in the field during the Covid-19 pandemic
  • #ServierDiversity program combats discrimination and promotes equal opportunities

Governance Achievements

  • Compliance policy established in line with its vocation, with Ethical Charter and Code of Conduct
  • Servier 1st class partner program develops long-term and transparent relationships with partners
  • Responsible purchasing approach inspired by ISO 20400, with e-learning course for purchasers
  • EcoVadis platform used to assess suppliers according to financial, ethical, social and environmental criteria
  • Transparency of clinical trials with reports and information on clinicaltrials.servier.com

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • -25% Greenhouse Gas emissions by 2030
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Rising cost of innovation creating pressure on prices
  • Reforms in healthcare systems to provide affordable care
  • Emergence of disruptive new players in the industry
  • Aging population and rise of chronic diseases
  • Persistent unmet medical needs
  • Climate change, biodiversity loss, and environmental damage
  • Growing expectations from companies regarding non-financial issues
  • Patients taking more control of their healthcare
  • Covid-19 pandemic
Mitigation Strategies
  • Investing 23% of revenue from brand-name medicines in R&D
  • Adapting strategies, R&D resources, and production facilities
  • Implementing measures to reduce environmental footprint
  • Adjusting management practices to attract and engage talent
  • Adopting a “beyond the pill” approach with patient services
  • Developing partnerships with patient groups
  • Implementing HSE policy and SAFE program for health and safety
  • #ServierDiversity program for diversity and inclusion
  • Servier Climate Commitment program to reduce GHG emissions
  • EcoDesign by Servier program to integrate eco-design principles into the medicine life cycle
  • Serialization and traceability program to combat counterfeit medicines
  • Collaboration with authorities to combat counterfeit medicines
  • My Health Partner platform for patients with chronic diseases
  • Local Shared Value program to measure and optimize socioeconomic benefits for regions
  • Mécénat Servier Charity Fund to assist general interest initiatives

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Servier 1st class partner program
  • Responsible purchasing charter
  • EcoVadis platform for supplier assessment

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: ISO 26000

Certifications: ISO 14001, ISO 50001, Top Employer Europe

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • SDG 3
  • SDG 5
  • SDG 8
  • SDG 12
  • SDG 13

Servier's ambitions are identified with five of the United Nation’s Sustainable Development Goals

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Top Employer Europe

Reporting Period: 2020-2021

Environmental Metrics

Total Carbon Emissions:33,672 tCO2e (2020/2021)
Scope 1 Emissions:15,000 tCO2e (2020/2021)
Scope 2 Emissions:7,863 tCO2e (2020/2021)
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:259,825 MWh (2020/2021)
Water Consumption:778,119 m³ (2020/2021)
Waste Generated:48,592.25 tons (2020/2021)
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Product quality and safety
  • Anticounterfeiting
  • Eco-design
  • Global approach to health care
  • Access to health care
  • Local development and community engagement
  • Climate change and responsible use of resources
  • Effluent and waste management
  • Health and safety at work
  • Employee well-being
  • Diversity, inclusion and equal opportunities
  • Managerial practices
  • Business ethics
  • Responsible purchasing
  • Ethics and transparency of clinical trials
  • Responsible marketing and promotion
  • Stakeholder Engagement

Environmental Achievements

  • 13% reduction in greenhouse gas emissions per box of medicine produced in 2019 compared to 2016
  • 88% of IT equipment at French sites reused
  • 100% of electrical energy consumed by Servier Spain from renewable sources since May 2020
  • 96% reduction in CO2 emissions per ton per kilometer in Brazil by switching from air to sea transport

Social Achievements

  • More than 45% of Group managers are women
  • Launched #ServierDiversity program to promote diversity and inclusion
  • Launched SAFE program to improve health and safety at work
  • Collaborated with 19 international patient associations in 2020/2021

Governance Achievements

  • Implemented First Class Partner program for responsible purchasing
  • 100% of strategic suppliers evaluated on their CSR practices by 2022
  • Implemented anti-corruption e-learning and Ethics Charter and Code of Conduct e-reading

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Reduce greenhouse gas emissions by 25% between 2016 and 2030
Short-term Goals:
  • Evaluate the environmental impact of 100% of its new industrial chemical syntheses by 2023
  • Organize EcoDesign training for employees by 2023
  • Integrate eco-design principles into the packaging of new brand-name products by 2025
  • Include biodiversity criteria in the specifications for the purchase of raw materials by 2023
  • At least 40% of women in top management by 2024

Environmental Challenges

  • Climate change
  • Reducing environmental impact of medicines
  • Promoting diversity and inclusion
  • Ensuring health and safety at work
  • Responsible purchasing and supply chain management
Mitigation Strategies
  • EcoDesign by Servier program
  • #ServierDiversity program
  • SAFE program
  • First Class Partner program
  • Servier Climate Commitment program

Supply Chain Management

Supplier Audits: 100% of strategic suppliers evaluated by 2022 using EcoVadis

Responsible Procurement
  • Responsible Purchasing Charter
  • EcoVadis platform for supplier evaluation

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (SDGs)

Certifications: ISO 14001, ISO 50001

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • SDG 3
  • SDG 5
  • SDG 8
  • SDG 10
  • SDG 12
  • SDG 13

Servier's CSR strategy is aligned with the UN Sustainable Development Goals

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2021-2022

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:58,780 tCO2e/year
Scope 2 Emissions:31,133 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:462,429 MWh/year (including 20,548 MWh of renewable energy)
Water Consumption:1.19 million m3/year
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Climate Change
  • Diversity & Inclusion
  • Governance
  • Patient Focus
  • Employee Well-being
  • Biodiversity

Environmental Achievements

  • 7.7% year-on-year reduction in scope 1 and 2 greenhouse gas emissions
  • 5.2% reduction in air freight between Loiret (France) and Arklow (Ireland), switching to sea freight
  • 25% increase in sea freight
  • 30,000 tons of CO2 equivalent offset in 2022

Social Achievements

  • Launched #BecauseIsayso #Checkyourpressure campaign to raise awareness about blood pressure
  • Launched the fourth edition of #Takeyourmedicine campaign
  • Mécénat Servier supported 29 non-profit organizations
  • 2,208 employee commitments through Mécénat Servier
  • 4.23/5 overall engagement score among Servier Group employees
  • 79% of employees would recommend Servier as a great place to work
  • 42 HR labels obtained in 2022
  • Improved patient adherence by over 20% in CONCORD study
  • Launched SHAPE program in collaboration with Digestive Cancers Europe (DiCE)

Governance Achievements

  • Included corporate social responsibility in the bylaws of the non-profit Foundation
  • Established a strategic CSR committee
  • Set objectives for 2030 across all CSR indicators

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Annual revenue of €8 billion and EBITDA exceeding 30% by 2030
  • One launch per year (new indication or medicine in oncology and a new Single Pill Combination in cardiometabolism and venous diseases) by 2030
  • One launch in neuroscience and immuno-inflammation by 2030
  • 25% reduction in greenhouse gas emissions by 2030
  • Offset the equivalent of all direct greenhouse gas emissions by 2030
  • 100% of Servier entities to earn an HR label by 2030
  • 100% of industrial and R&D facilities to have ISO 50001 certification by 2030
Short-term Goals:
  • Reach €6 billion in consolidated sales revenue by 2025
  • Reach €1.3 billion in EBITDA by 2025
  • Reach €1 billion in oncology revenue by 2025
  • Launch one new molecular entity by 2025
  • Reach optimal employee engagement by 2025 (4.4/5)
  • Increase the proportion of women in senior management positions to 40% by 2025
  • 80% of industrial and R&D facilities to have ISO 50001 certification by 2025
  • 16% reduction in greenhouse gas emissions by 2025

Environmental Challenges

  • Global and national inequalities in healthcare access
  • Unmet medical needs
  • Climate change and its impact on business continuity and supply chains
  • Geopolitical instability and its impact on supply chains and market access
  • Rising costs of energy and raw materials
  • Inflation
  • Competition in the pharmaceutical industry
  • Patient adherence to long-term treatments
  • Recruitment and retention of talent
Mitigation Strategies
  • Donation of medicines and aid to Ukraine
  • Participation in Access Accelerated partnership
  • Continuous adaptation of production facilities and supply chain
  • Significant presence in emerging economies
  • EcoDesign program to integrate environmental concerns into the medicine life cycle
  • Target of 25% reduction in greenhouse gas emissions by 2030
  • Investment in R&D and innovation
  • Partnerships with patient organizations
  • Employee training and development programs
  • Digital transformation initiatives
  • Servier Social Observatory to anticipate changes in society’s attitude to work

Supply Chain Management

Supplier Audits: 369 suppliers and subcontractors assessed by EcoVadis; 66% of strategic suppliers assessed

Responsible Procurement
  • First-class Partner program to ensure supplier compliance with sustainable development principles and respect for human rights, health and safety, and the environment
  • EcoVadis assessment of suppliers

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
Transition Risks
  • Regulatory changes
  • Policy changes
Opportunities
  • Innovation and low-carbon solutions

Reporting Standards

Frameworks Used: IIRC

Certifications: ISO 14001, ISO 50001, Top Employer Europe 2022, Great Place to Work, HappyIndex® Trainees International

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • SDG 3
  • SDG 5
  • SDG 8
  • SDG 12
  • SDG 13
  • SDG 14
  • SDG 15

Servier's initiatives contribute to these goals through various programs related to health, gender equality, economic growth, responsible consumption and production, climate action, and biodiversity protection.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Top Employer Europe 2022
  • Great Place to Work
  • HappyIndex® Trainees International

Reporting Period: 2022-2023

Environmental Metrics

Total Carbon Emissions:1,170,000 tCO2eq (2021/2022)
Scope 1 Emissions:77,597 tCO2eq (2021/2022)
Scope 2 Emissions:37,692 tCO2eq (2021/2022)
Scope 3 Emissions:954,711 tCO2eq (2021/2022)
Renewable Energy Share:13% (2022/2023)
Total Energy Consumption:422,021 MWh (2022/2023)
Water Consumption:1,099,676 m3 (2022/2023)
Waste Generated:80,765 tons (2022-2023)
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Patients
  • Employees
  • Partners and Communities
  • The Planet

Environmental Achievements

  • Reduced Scope 1 & 2 greenhouse gas emissions by 11% between 2021/2022 and 2022/2023
  • Reduced Group’s energy consumption by 15% compared with the previous year
  • Increased renewable electricity in the Group’s electricity consumption to more than 13%
  • Reduced water consumption by 14%

Social Achievements

  • Ranked 14th (up 12 places) in the PatientView survey on the reputation of pharmaceutical companies with patient organizations
  • Improved employee engagement score to 4.32 out of 5
  • Increased percentage of women in top management positions to 29%
  • Awarded the Cap’Handéo label for “companies committed to their employee caregivers”

Governance Achievements

  • Deployed a compliance program in accordance with legal obligations and the Group’s mission
  • Rolled out a Group-wide framework for safety fundamentals - the Safety Golden Rules

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Reduce Scope 1 & 2 greenhouse gas emissions by 42% and Scope 3 emissions by 25% compared with 2021/2022 by 2030
  • 100% of French sites hold a BiodiverCity Life® or equivalent label by 2030
  • 100% of the brand-name medicines integrate ecodesign principles by 2030
  • Women in 40% of positions for Group governance bodies by 2030
Short-term Goals:
  • Reduce Scope 1 & 2 greenhouse gas emissions by 16% and Scope 3 emissions by 10% compared with 2021/2022 by 2025
  • Distribute an onsite biodiversity management guide for the Group’s entire real estate stock by 2025
  • 100% of new brand-name medicines integrate ecodesign principles for the packaging by 2025
  • Women in 40% of top management positions by 2025

Environmental Challenges

  • Reducing greenhouse gas emissions across the entire value chain
  • Reducing the impact of medicinal products and activities on biodiversity
  • Counterfeiting of medicinal products
Mitigation Strategies
  • Implementing actions around four core pillars: energy, purchased goods and services, transport and distribution of medicinal products, and mobility
  • Incorporating biodiversity criteria into specifications for purchasing natural raw materials
  • Reducing water effluents generated by activities
  • Implementing a robust organization to combat counterfeit medicines built around detection, prevention, and proactive action

Supply Chain Management

Supplier Audits: 74% of our top 100 suppliers are assessed with EcoVadis

Responsible Procurement
  • CSR assessment based on the EcoVadis platform
  • Incorporating climate elements when assessing bidders for tenders
  • Incorporating a biodiversity clause into invitations to tender for natural materials

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: GRI

Certifications: ISO 50001, ISO 14001, Top Employer Europe

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Objectives of CSR programs are aligned with the United Nations’ Sustainable Development Goals (SDGs). The Group contributes to 10 SDGs relating directly to its activities.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Cap’Handéo label